APL-030

N/A

Report date: 2024/06/07 14:41:22
NME

Base Information

Drug NameAPL-030
Drug Alias NameAPL-030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 modulators
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImperial College LondonLausanne University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesLausanne University HospitalImperial College London
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A